COVID-19 vaccine: Pfizer CEO sold shares on announcement day
Pfizer CEO Albert Bourla sold US lab stock for $ 5.6 million on the day the group announced good preliminary results on the effectiveness of a COVID-19 vaccine.
Share November 11, 2020 3:39 p.m. Share COVID-19 vaccine: Pfizer CEO sold shares on the day of the announcement AFP Agence France-Presse WASHINGTON – Pfizer CEO Albert Bourla sold for $ 5.6 million of 'actions by the American laboratory on the day the group announced good preliminary results on the effectiveness of a vaccine against COVID-19.
According to a document filed with the US Securities Authorities, Mr. Bourla sold 132,508 securities for $ 41.94 on Wall Street, equivalent to nearly $ 5.6 million.
Vice-president of laboratories, Sally Susman, also sold on Monday for $ 1.8 million, selling 43,662 titles.
Pfizer's action had soared by more than 7% on Monday when the American laboratory announced that its vaccine developed with the German company BioNTech – which had taken 13.91% – was “effective” at 90% against COVID-19 .
Asked by AFP about these sales of securities, Pfizer did not respond.
According to a spokesperson quoted on the CNN site, these transactions were already part of a periodic divestment plan put in place by the head of the group when the title reaches a certain price.
These disposals at this price would have been scheduled as part of their personal financial management, since August 2019 for the CEO Albert Bourla and since November 2019 for the vice-president.